English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Epidemiological evidence suggests an inverse correlation between wine consumption and the incidence of cardiovas- cular and neurodegenerative disorders. Although white wines are generally low in polyphenol content as compared to red wines, Champagne wine has been shown to contain relatively high amounts of phenolic acids that may exert protective cellular actions in vivo. Recent evidence suggest that Champagne phenolic acids may express their beneficial properties through their interaction with cellular signaling pathways and related machinery that mediate cell function under both normal and pathological condi- tions. In this review we aim to provide an overview of the role that Champagne consumption plays in maintaining cardiovascular health and cognitive function. We discuss epidemiological data, human intervention study findings, as well as animal and in vitro studies in support of these actions and we consider how their biological mechanisms at the cellular level may underpin their physiological effects. Together, these data indicate that polyphenols present in Champagne may hold cardioprotective and neuroprotective potential in delaying the onset of degenerative disorders.

The impact of Champagne wine consumption on vascular and cognitive functions